Apparatuses, methods, and other embodiments associated with determining organ viability are described. According to one embodiment, an apparatus includes logic configured to apply nuclear magnetic resonance (NMR) energy to a kidney positioned in a hypothermic pulsative perfusion (HPP) apparatus. The NMR energy is produced according to an MRS 31P specific pulse sequence. The HPP apparatus has an integrated RF coil. The HPP may also have an integrated magnet. The RF coil is positioned and oriented to facilitate optimizing 31P MRS of the kidney. The apparatus also includes logic configured to receive spectrum data from the kidney. The spectrum data is produced in response to applying the NMR energy to the kidney. The apparatus also includes logic configured to provide objective, quantitative kidney viability data (e.g., PME/Pi, ATP/ADP) from the spectrum data. More generally, MRI/MRS compatible HPP apparatuses are configured to interact with dedicated NMR spectroscopy apparatuses.